202 related articles for article (PubMed ID: 7923189)
1. Molecular determinants of dysplasia in colorectal lesions.
Jen J; Powell SM; Papadopoulos N; Smith KJ; Hamilton SR; Vogelstein B; Kinzler KW
Cancer Res; 1994 Nov; 54(21):5523-6. PubMed ID: 7923189
[TBL] [Abstract][Full Text] [Related]
2. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.
Smith AJ; Stern HS; Penner M; Hay K; Mitri A; Bapat BV; Gallinger S
Cancer Res; 1994 Nov; 54(21):5527-30. PubMed ID: 7923190
[TBL] [Abstract][Full Text] [Related]
3. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
4. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ
Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810
[TBL] [Abstract][Full Text] [Related]
6. [Genome analyses for precancerous lesions in the gastrointestinal tract].
Sowa M; Nakata B
Gan To Kagaku Ryoho; 2000 Mar; 27(3):335-40. PubMed ID: 10740625
[TBL] [Abstract][Full Text] [Related]
7. Association of APC gene mutations and histological characteristics of colorectal adenomas.
De Benedetti L; Sciallero S; Gismondi V; James R; Bafico A; Biticchi R; Masetti E; Bonelli L; Heouaine A; Picasso M
Cancer Res; 1994 Jul; 54(13):3553-6. PubMed ID: 8012980
[TBL] [Abstract][Full Text] [Related]
8. APC and p53 mutations in de novo colorectal adenocarcinomas.
Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
[TBL] [Abstract][Full Text] [Related]
9. Multistep carcinogenesis in colorectal cancers.
Takami K; Yana I; Kurahashi H; Nishisho I
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():190-6. PubMed ID: 8629105
[TBL] [Abstract][Full Text] [Related]
10. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP).
Ichii S; Takeda S; Horii A; Nakatsuru S; Miyoshi Y; Emi M; Fujiwara Y; Koyama K; Furuyama J; Utsunomiya J
Oncogene; 1993 Sep; 8(9):2399-405. PubMed ID: 8395678
[TBL] [Abstract][Full Text] [Related]
11. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
12. Cellular kinetics and K-ras codon 12 mutations according to histomorphometric type of colorectal polyps with epithelial serrated proliferation.
Hamatani S; Wada R; Morita A; Hasegawa C; Mitsuda A; Hatori T; Nonaka H; Takahashi K; Gomi S; Shibuya K
Oncol Rep; 2005 Jul; 14(1):121-7. PubMed ID: 15944778
[TBL] [Abstract][Full Text] [Related]
13. [Precancerous lesion in colorectal cancer].
Nagawa H; Yamagata S; Muto T
Gan To Kagaku Ryoho; 1995 Dec; 22(14):2043-7. PubMed ID: 8607613
[TBL] [Abstract][Full Text] [Related]
14. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
[TBL] [Abstract][Full Text] [Related]
15. A genetic basis for the multi-step pathway of colorectal tumorigenesis.
Fearon ER
Princess Takamatsu Symp; 1991; 22():37-48. PubMed ID: 1668892
[TBL] [Abstract][Full Text] [Related]
16. Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.
Smith G; Carey FA; Beattie J; Wilkie MJ; Lightfoot TJ; Coxhead J; Garner RC; Steele RJ; Wolf CR
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9433-8. PubMed ID: 12093899
[TBL] [Abstract][Full Text] [Related]
17. Application of cycling gradient capillary electrophoresis to detection of APC, K-ras, and DCC point mutations in patients with sporadic colorectal tumors.
Minarik M; Minarikova L; Hrabikova M; Minarikova P; Hrabal P; Zavoral M
Electrophoresis; 2004 Apr; 25(7-8):1016-21. PubMed ID: 15095442
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
[TBL] [Abstract][Full Text] [Related]
19. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester.
Jackson PE; Hall CN; Badawi AF; O'Connor PJ; Cooper DP; Povey AC
Mol Carcinog; 1996 May; 16(1):12-9. PubMed ID: 8634090
[TBL] [Abstract][Full Text] [Related]
20. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.
Lauschke H; Caspari R; Friedl W; Schwarz B; Mathiak M; Propping P; Hirner A
Cancer Detect Prev; 2001; 25(1):55-61. PubMed ID: 11270422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
